84 related articles for article (PubMed ID: 9044368)
1. The role of serum amyloid P (SAP) component in Alzheimer's disease.
Urbányi Z
Neurobiology (Bp); 1996; 4(3):283-4. PubMed ID: 9044368
[No Abstract] [Full Text] [Related]
2. Serum amyloid P component induces TUNEL-positive nuclei in rat brain after intrahippocampal administration.
Urbányi Z; Sass M; Laszy J; Takács V; Gyertyán I; Pázmány T
Brain Res; 2007 May; 1145():221-6. PubMed ID: 17337265
[TBL] [Abstract][Full Text] [Related]
3. Glycosaminoglycans inhibit neurodegenerative effects of serum amyloid P component in vitro.
Urbányi Z; Forrai E; Sárvári M; Likó I; Illés J; Pázmány T
Neurochem Int; 2005 May; 46(6):471-7. PubMed ID: 15769549
[TBL] [Abstract][Full Text] [Related]
4. Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease.
Pedersen WA; McCullers D; Culmsee C; Haughey NJ; Herman JP; Mattson MP
Neurobiol Dis; 2001 Jun; 8(3):492-503. PubMed ID: 11442356
[TBL] [Abstract][Full Text] [Related]
5. Complement component C1q inhibits beta-amyloid- and serum amyloid P-induced neurotoxicity via caspase- and calpain-independent mechanisms.
Pisalyaput K; Tenner AJ
J Neurochem; 2008 Feb; 104(3):696-707. PubMed ID: 17986223
[TBL] [Abstract][Full Text] [Related]
6. Serum amyloid P component-induced cell death in primary cultures of rat cerebral cortex.
Urbányi Z; Lakics V; Erdö SL
Eur J Pharmacol; 1994 Aug; 270(4):375-8. PubMed ID: 7805789
[TBL] [Abstract][Full Text] [Related]
7. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.
Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P
Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224
[TBL] [Abstract][Full Text] [Related]
8. Nicergoline, a drug used for age-dependent cognitive impairment, protects cultured neurons against beta-amyloid toxicity.
Caraci F; Chisari M; Frasca G; Canonico PL; Battaglia A; Calafiore M; Battaglia G; Bosco P; Nicoletti F; Copani A; Sortino MA
Brain Res; 2005 Jun; 1047(1):30-7. PubMed ID: 15882840
[TBL] [Abstract][Full Text] [Related]
9. Serum amyloid p component as a biomarker in mild cognitive impairment and Alzheimer's disease.
Verwey NA; Schuitemaker A; van der Flier WM; Mulder SD; Mulder C; Hack CE; Scheltens P; Blankenstein MA; Veerhuis R
Dement Geriatr Cogn Disord; 2008; 26(6):522-7. PubMed ID: 19052452
[TBL] [Abstract][Full Text] [Related]
10. [Does acidosis in brain play a role in Alzheimer's disease?].
Pirchl M; Humpel C
Neuropsychiatr; 2009; 23(3):187-92. PubMed ID: 19703385
[TBL] [Abstract][Full Text] [Related]
11. alpha-Synuclein enhances secretion and toxicity of amyloid beta peptides in PC12 cells.
Kazmierczak A; Strosznajder JB; Adamczyk A
Neurochem Int; 2008 Dec; 53(6-8):263-9. PubMed ID: 18804502
[TBL] [Abstract][Full Text] [Related]
12. Preferential association of serum amyloid P component with fibrillar deposits in familial British and Danish dementias: similarities with Alzheimer's disease.
Rostagno A; Lashley T; Ng D; Meyerson J; Braendgaard H; Plant G; Bojsen-Møller M; Holton J; Frangione B; Revesz T; Ghiso J
J Neurol Sci; 2007 Jun; 257(1-2):88-96. PubMed ID: 17374542
[TBL] [Abstract][Full Text] [Related]
13. A novel neurotrophic agent, T-817MA [1-{3-[2-(1-benzothiophen-5-yl) ethoxy] propyl}-3-azetidinol maleate], attenuates amyloid-beta-induced neurotoxicity and promotes neurite outgrowth in rat cultured central nervous system neurons.
Hirata K; Yamaguchi H; Takamura Y; Takagi A; Fukushima T; Iwakami N; Saitoh A; Nakagawa M; Yamada T
J Pharmacol Exp Ther; 2005 Jul; 314(1):252-9. PubMed ID: 15798005
[TBL] [Abstract][Full Text] [Related]
14. Serum amyloid P component induces neuronal apoptosis and beta-amyloid immunoreactivity.
Urbányi Z; László L; Tomasi TB; Tóth E; Mekes E; Sass M; Pázmány T
Brain Res; 2003 Oct; 988(1-2):69-77. PubMed ID: 14519527
[TBL] [Abstract][Full Text] [Related]
15. Perineuronal nets protect against amyloid beta-protein neurotoxicity in cultured cortical neurons.
Miyata S; Nishimura Y; Nakashima T
Brain Res; 2007 May; 1150():200-6. PubMed ID: 17397805
[TBL] [Abstract][Full Text] [Related]
16. Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease.
Lorenzo A; Yuan M; Zhang Z; Paganetti PA; Sturchler-Pierrat C; Staufenbiel M; Mautino J; Vigo FS; Sommer B; Yankner BA
Nat Neurosci; 2000 May; 3(5):460-4. PubMed ID: 10769385
[TBL] [Abstract][Full Text] [Related]
17. Human amyloidosis, Alzheimer disease and related disorders.
Castaño EM; Frangione B
Lab Invest; 1988 Feb; 58(2):122-32. PubMed ID: 3276958
[No Abstract] [Full Text] [Related]
18. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease.
Busche MA; Eichhoff G; Adelsberger H; Abramowski D; Wiederhold KH; Haass C; Staufenbiel M; Konnerth A; Garaschuk O
Science; 2008 Sep; 321(5896):1686-9. PubMed ID: 18802001
[TBL] [Abstract][Full Text] [Related]
19. RCAN1-1L is overexpressed in neurons of Alzheimer's disease patients.
Harris CD; Ermak G; Davies KJ
FEBS J; 2007 Apr; 274(7):1715-24. PubMed ID: 17331188
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of naturally occurring biflavonoids.
Kang SS; Lee JY; Choi YK; Song SS; Kim JS; Jeon SJ; Han YN; Son KH; Han BH
Bioorg Med Chem Lett; 2005 Aug; 15(15):3588-91. PubMed ID: 15978805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
